Skip to main content

Athenex, Inc.

ATNXDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001300699

Athenex, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on May 8, 2023; 30 institutions reported holding it in 13F filings for Q1 2023, worth $2.43M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Athenex, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ATNX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders72254−16
Shares48.1M1.46M40.2M−6.43M (−13.8%)
Value$13.0M$394.0K$5.93M−$6.63M (−52.8%)

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Athenex, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ATNX in Q4 2022
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP44,800$6.61K0.00%
Susquehanna International Group, LLP44,102$6.50K0.00%
Janney Montgomery Scott LLC39,190$6.00K0.00%
StoneX Group Inc.11,360$1.68K0.00%
Raymond James Financial Services Advisors, Inc.10,700$1.58K0.00%
HRT Financial LP11,396$1.00K0.00%
Fortis Advisors, LLC1,000$1480.00%

Sold out (23)

Institutions that held Athenex, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (2)

Institutions that held Athenex, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ATNX in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Empery Asset Management, LP1,452,103$391.0K
Eaton Vance Management12,000$3.00K